Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. The EPIC Investigators.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples